STERIS plc
STE Healthcare Medical Devices
STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025. In the quarter to June 2026, revenue grew 7.30%, EPS grew 13.9%, free cash flow fell 14.4% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
Follow STE
STERIS plc (STE) Shares outstanding
STERIS plc's shares outstanding at the end of fiscal 2026 was $98.7M, unchanged from fiscal 2025. At the end of the quarter to 30 June 2026 it was $97.9M. Over the past ten years it has ranged from $60.0M (fiscal 2015) to $100.2M (fiscal 2023); the current reading is higher than 75% of that period. STERIS plc ranks 32nd of 147 Medical Devices companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2026 | $98.7M | (0.40%) |
| FY2025 | $99.1M | (0.30%) |
| FY2024 | $99.4M | (0.84%) |
| FY2023 | $100.2M | 1.95% |
| FY2022 | $98.3M | 14.47% |
| FY2021 | $85.9M | 0.30% |
| FY2020 | $85.6M | 0.20% |
| FY2019 | $85.5M | (0.29%) |
| FY2018 | $85.7M | (0.44%) |
| FY2017 | $86.1M | 20.95% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $97.9M | (0.81%) |
| Mar 2026 | $98.7M | 0.10% |
| Dec 2025 | $98.6M | (0.20%) |
| Sep 2025 | $98.8M | 0.00% |
| 42 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| PHG Koninklijke Philips N.V. compare | $968.6M |
| GEHC GE HealthCare Technologies Inc. compare | $454.0M |
| SNN Smith & Nephew SNATS, Inc. compare | $449.4M |
| DXCM DexCom, Inc. compare | $390.1M |
| ZBH Zimmer Biomet Holdings, Inc. compare | $192.8M |
| GMED Globus Medical, Inc. compare | $137.4M |
| STE STERIS plc | $97.9M |
| PEN Penumbra, Inc. compare | $39.6M |
| BIO.B Bio-Rad Laboratories, Inc. compare | $26.8M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on STE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement